Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept (Q28075557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

review article

1 reference

title

Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

João Rafael de Oliveira Dias

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

Eduardo Büchele Rodrigues

27 March 2020

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Gabriel Costa de Andrade

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Eduardo Amorim Novais

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Michel Eid Farah

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

1 reference

1 February 2016

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Retina and Vitreous

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

Molecularly targeted drugs for metastatic colorectal cancer

27 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

VEGF-Trap: a VEGF blocker with potent antitumor effects

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

The biology of vascular endothelial growth factor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Ranibizumab for neovascular age-related macular degeneration

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Profile of conbercept in the treatment of neovascular age-related macular degeneration

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Ziv-aflibercept in macular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Intravitreal injection of ziv-aflibercept in patient with refractory age-related macular degeneration.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Preclinical investigations of intravitreal ziv-aflibercept.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Intravitreal aflibercept for diabetic macular edema

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Aflibercept: a novel VEGF targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Ocular angiogenesis: translating preclinical indications to successful clinical development

2 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Predicted biological activity of intravitreal VEGF Trap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40942-016-0026-Y

Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088480

Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1

27 November 2018

1 reference

12 December 2020

Chemical mediators of intraocular neovascularization

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study

1 reference

12 December 2020

10.1186/S40942-016-0026-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 March 2020

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27847621%20AND%20SRC:MED&resulttype=core&format=json